$1.85
0.010.54%
Últ. Act.: Nov 6, 5:20 PM
The average analyst price target for Fortress Biotech is $13.25, 604.8% above the current price. Of 4 analysts, 4 rate it Buy. Targets range from $5 to $17. The latest change came on Aug 21, 2025, when HC Wainwright & Co. lowered its price target on Fortress Biotech from $26 to $17 and kept a Buy rating.
Price Target Range — 8 Quarters
Analyst Consensus — 4 Analysts
Rating Trend — Last 9 Months